BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at
the BMO Capital Markets 9th Annual Focus on Healthcare
Conference on Wednesday, August 5, 2009 at the Millennium
Broadway Hotel in New York City.
BioScrip's Chairman and Chief Executive Officer, Richard H. Friedman,
and Stanley G. Rosenbaum, Executive Vice President and Chief Financial
Officer will present at 9:30 AM ET (Eastern Time). Investors may access
a live audio web cast of BioScrip's presentation at the following link: http://www.bmocm.com/conferences/2009healthcare/webcast/.
A web cast replay of the presentation can also be accessed via
BioScrip’s website at www.bioscrip.com,
under the Investors section.
About BioScrip, Inc.
BioScrip, Inc. is a specialty pharmaceutical healthcare organization
that partners with patients, physicians, healthcare payors and
pharmaceutical manufacturers to provide access to medications and
management solutions to optimize outcomes for chronic and other complex
health care conditions.
Forward Looking Statements-Safe Harbor
This press release may contain statements which constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, including statements regarding the
intent, belief or current expectations of the Company, its directors, or
its officers with respect to the future operating performance of the
Company, Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve risks
and uncertainties, and that actual results may differ materially from
those in the forward-looking statements as a result of various factors.
Important factors that could cause such differences are described in the
Company’s periodic filings with the Securities and Exchange Commission.
BioScrip, Inc.
Stanley G. Rosenbaum
Executive Vice President
and Chief Financial Officer
952-979-3768
srosenbaum@bioscrip.com
or
In-Site
Communications
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com
